preeclampsia
New data has demonstrated that DNA fragment size differences that discriminate preeclampsia from healthy controls can be detected using a lower-cost PCR method.
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
A ratio of the two biomarkers detected by the 30-minute clinical chemistry assays can be used for prognosis and treatment of preeclampsia.
Biora Therapeutics Divests Preeclampsia Test to Avero Diagnostics
Biora previously operated as a women's health diagnostic company called Progenity, but in mid-2021 shifted its focus to drug delivery and therapeutics.
NICE Recommends PerkinElmer, Roche, Quidel Assays for Preeclampsia Testing
The four assays are PerkinElmer's Delfia Xpress PLGF 1-2-3 and Delfia Xpress sFlt-1/PLGF 1-2-3, Roche's Elecsys immunoassay sFlt-1/PLGF ratio, and Quidel's Triage PLGF Test.
Mirvie Raises $60M in Series B Funding
The company plans to use the funding to propel the clinical and commercial development of its Mirvie RNA testing platform for pregnancy health.